(Q33591533)

28 July 2017

1 reference

title

Anthrax vaccine. Model of a response to the biologic warfare threat (English)

1 reference

28 July 2017

Nass M

1

1 reference

28 July 2017

1 March 1999

1 reference

Infectious Disease Clinics of North America

28 July 2017

1 reference

28 July 2017

13

1 reference

28 July 2017

1

1 reference

28 July 2017

187-208, viii

1 reference

Changing the consent rules for Desert Storm.

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

The Birth of the U.S. Biological-Warfare Program

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Field Evaluation of a Human Anthrax Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Admission on Gulf War vaccines spurs debate on medical records.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Anthrax: virulence and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Postexposure prophylaxis against experimental inhalation anthrax

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Immunization studies with attenuated strains of Bacillus anthracis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Recent advances in the development of an improved, human anthrax vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Human live anthrax vaccine in the former USSR.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Anthrax post-vaccinal cell-mediated immunity in humans: kinetics pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Development of novel vaccines against anthrax in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Anthrax vaccines: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

1 reference

7 January 2021

Neurological and physiological responses of the primate to anthrax toxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

Iraq's biological weapons. The past as future?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970050-7

7 January 2021

10.1016/S0891-5520(05)70050-7

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10198799